Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!

Digital illustration of Mitochondria


The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April 2022. It's our annual meeting packed with short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology. This one day hybrid conference is ideal for researchers with an interest in mitochondria from both academia and pharma. It will include a range of short talks and posters on cancer metabolism, neuroscience, diabetes, mitochondrial disorders and general mitochondrial biology.  


Download the full programme here.


Book online here.

Face to face registration is now open with a £30 registration fee. Please note that those wishing to present a poster need to register for the face to face meeting. If you have previously registered for online-only option, please feel free to register for the face event if you wish to do so.

We are currently limited on in-person numbers to 58 people.

 The online-only attendance option is free of charge.

Venue: This event will be hybrid. It will take place on Zoom and in-person attendance will take place in the Academic Block at the John Radcliffe Hospital, Oxford OX3 9DU. See directions and map.

The last booking date for this event is TBC.

For all conference enquiries, please contact


Please submit abstracts to be considered  for short  talks and posters to Danielle Hoare at

In the E-mail please use 'Abstract for MitOX 2022as the subject line and kindly state if you wish to be considered for a talk only, poster only or either a talk or a poster.

Abstracts should be a standard  conference format on a single side of A4.

The deadline for abstracts is the 20th March 2022.






Title of talk


Karl Morten, University of Oxford



Chair: Jo Poulton, University of Oxford

First Session: Mitochondrial DNA, expression and recombination


Dan Mishmar, Ben Gurion University, Israel

The impact of mitochondrial gene expression regulation, and its coordination with the nucleus, on disease


Ana Victoria Lechuga-Vieco, University of Oxford

Mitochondrial heterogeneity: friend or foe?.


Yizhou Yu, Cambridge

Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease


Hansong Ma, University of Cambridge

Mitochondrial recombination reveals genetic interactions that modulate the phenotypic expression of pathogenic mtDNA mutants


Coffee Break



Chair: Rhiannon McGeehan, University of Portsmouth

Second Session: Cancer


Payam Gammage, Glasgow

The impact of cancer-associated mtDNA mutations on tumour metabolism and the microenvironment


Markus Ralser, The Francis Crick

Institute, MRC

The metabolic growth limitations of petite cells lacking the mitochondrial genome


Nuno Santos Leal, University of Cambridge

Contacts between mitochondria and the endoplasmic reticulum protect from mitochondrial toxicity by activating the PERK/ATF4 branch of ER stress 


Mike Duchen, UCL

Rewiring cell signalling pathways in pathogenic mtDNA mutations


Sponsors Talks   BMG Labtech, Promega, Agilent, Atlantic imaging



Lunch and Poster Session I



Katharina  Schlacher, Houston, USA

BRCA/FANC tumor suppressor roles in mitochondrial genome instability and inflammation


Chair: Tom Nichol, University of Oxford)

Third Session; Mitophagy and Dynamics


Pollard Lecture William Mair (Harvard) 

Metabolic Flexibility, Mitochondrial Dynamics & Healthy Aging


Brent Ryan, University of Oxford 

Integrating animal and cellular models to understand mitochondrial dysfunction in Parkinson’s disease


Tea & Poster Session II  



Chair: Kerstin Timm, University of Oxford

Fourth Session: Mitochondrial medicine


Leanne Hodson, University of Oxford

Tracing fat to determine factors influencing mitochondrial fatty acid oxidation in human


Lisa Heather, University of  Oxford

Diabetic cardiac mitochondria are resistant to the regulation of respiration by lipid intermediates


Robin Klemm, University of Oxford

Mechanisms controlling de novo lipogenesis based lipid droplet expansion during adiopcyte differentiation


Isabella Panfoli, Genova

The polyphenol Cirsiliol prevents the light-induced oxidative damage of the retinal rod outer segment in vitro


Close & Poster Prizes


Similar stories

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New imaging study could make diagnosing endometriosis quicker, more accurate and reduce the need for invasive surgery.

A new research study launches to investigate whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Endometriosis: pandemic backlog risks making it even harder for women to get help

The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.

New guidelines launched for diagnosis and management of Endometriosis

A new comprehensive document by the European Society of Human Reproduction and Embryology (ESHRE) outlines more than 100 recommendations on best practice on caring for women with Endometriosis.